- Home
- GRC vs COLL Comparison
GRC vs COLL Comparison
Compare GRC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRC
- COLL
- Stock Information
- Founded
- GRC 1933
- COLL 2002
- Country
- GRC United States
- COLL United States
- Employees
- GRC N/A
- COLL N/A
- Industry
- GRC Fluid Controls
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- GRC Industrials
- COLL Health Care
- Exchange
- GRC Nasdaq
- COLL Nasdaq
- Market Cap
- GRC 1.0B
- COLL 958.8M
- IPO Year
- GRC N/A
- COLL 2015
- Fundamental
- Price
- GRC $37.15
- COLL $30.13
- Analyst Decision
- GRC
- COLL Strong Buy
- Analyst Count
- GRC 0
- COLL 4
- Target Price
- GRC N/A
- COLL $43.75
- AVG Volume (30 Days)
- GRC 52.1K
- COLL 280.2K
- Earning Date
- GRC 07-25-2025
- COLL 08-07-2025
- Dividend Yield
- GRC 2.00%
- COLL N/A
- EPS Growth
- GRC 21.97
- COLL N/A
- EPS
- GRC 1.69
- COLL 1.25
- Revenue
- GRC $664,347,000.00
- COLL $664,283,000.00
- Revenue This Year
- GRC $4.50
- COLL $20.04
- Revenue Next Year
- GRC $4.50
- COLL $3.98
- P/E Ratio
- GRC $21.92
- COLL $23.86
- Revenue Growth
- GRC 0.92
- COLL 17.17
- 52 Week Low
- GRC $30.87
- COLL $23.23
- 52 Week High
- GRC $43.79
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- GRC 55.57
- COLL 55.25
- Support Level
- GRC $36.16
- COLL $29.11
- Resistance Level
- GRC $37.66
- COLL $30.30
- Average True Range (ATR)
- GRC 0.66
- COLL 0.71
- MACD
- GRC 0.02
- COLL -0.03
- Stochastic Oscillator
- GRC 79.49
- COLL 44.32
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.